Drugs / DIT309
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07052383 | Nov 2025 → Oct 2027 expected | osteosarcoma, soft tissue sarcoma | Tcelltech Inc. | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DIT309 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07052383 ↗ |